Life Insurance
Consensus Index

AI Consensus Fit Review

American Amicable Final Expense Insurance Fit Review for People With Heart Conditions

American Amicable is a good—but diagnosis-dependent—fit for a senior with heart conditions seeking $15,000–$25,000 of permanent final expense coverage.

Research: 2026-09-227 usable platform responsesRead the methodology ↗

Share

Answer Capsule

American Amicable is a good—but diagnosis-dependent—fit for a senior with heart conditions seeking $15,000–$25,000 of permanent final expense coverage. Four of the seven platforms in this study named American Amicable during the ranking stage, and six of seven returned a usable fit assessment. The strongest reason to consider it is its simplified-issue whole life lineup—Senior Choice, Golden Solution, and Lighthouse Legacy—which offers immediate, graded, and return-of-premium benefit structures and underwriting guidance that specifically addresses several cardiac histories. The main limitation is that current or documented congestive heart failure is listed as no coverage, and recent major cardiac events may only qualify for graded or return-of-premium benefits rather than full first-day coverage.

Research Snapshot

FieldFinding
Platform mentions in ranking stage4 of 7 platforms named American Amicable (google, kimi, openai, perplexity)
Share of included platform responses57.1% (4 of 7)
Average listed rank3.25
Best listed rank1 (perplexity)
Relevant product/model/planSenior Choice (Immediate, Graded, Return of Premium); Golden Solution; Lighthouse Legacy simplified-issue whole life
Overall use-case fitGood, with meaningful underwriting risk (4 platforms rated good; 2 rated mixed)
Research date2026-09-22

Why American Amicable Qualified for This Study

Questions This Section Answers

  • Is American Amicable a good choice for Final Expense Insurance for People With Heart Conditions?
  • How many AI platforms named American Amicable for final expense coverage with heart conditions?

American Amicable qualified because it was named by four of the seven platforms during ranking discovery and received a usable fit assessment from six of the seven, making it one of the more consistently surfaced carriers for this specific buyer profile. Its fit ratings were not unanimous: four platforms (openai, anthropic, google, kimi) rated it a good fit, while two (grok, perplexity) rated it mixed. The company's relevance rests on a permanent whole life product family with simplified underwriting and multiple benefit tiers, which directly matches a buyer who needs $15,000–$25,000 of coverage and may not qualify for immediate full benefits because of cardiac history [1].

The ranking-stage product names supplied for American Amicable were Eagle Premier Final Expense Whole Life, Lighthouse Legacy or Golden Solution whole life final-expense plans, and Senior Choice (Immediate Benefit) in level or graded form. One platform flagged that Eagle Premier Final Expense Whole Life is actually an Americo product, not an American Amicable product, and that American Amicable's primary final expense brands are Senior Choice and Golden Solution [4]. Another platform could not verify Eagle Premier, Lighthouse Legacy, or Golden Solution in official-source results and identified Senior Choice as the confirmed product [5]. This naming conflict is unresolved in the supplied evidence and is disclosed throughout this review.

The Product, Model, Plan, or Service Most Relevant to Final Expense Insurance for People With Heart Conditions

Questions This Section Answers

  • Which American Amicable plan should a buyer with a past heart attack choose for $15,000 to $25,000 of final expense coverage?
  • Does American Amicable Senior Choice offer immediate, graded, and return-of-premium options for applicants with heart conditions?

The most consistently documented American Amicable product for this use case is Senior Choice whole life, which includes immediate death benefit, graded death benefit, and return-of-premium versions [6]. Golden Solution is described as a final expense whole life plan with the same three-tier structure and issue ages 50–85 [8]. Lighthouse Legacy is documented in a company agent guide as simplified-issue whole life with immediate, graded, and return-of-premium benefit structures, issue ages 50–85, and a maximum of $25,000 for graded and return-of-premium plans [10].

The benefit structures matter for a cardiac buyer. The immediate-benefit plan pays 100% of the face amount from day one. The graded plan pays 30% in year one, 70% in year two, and 100% beginning in year three, with accidental death paid at 100% throughout [10]. The return-of-premium plan pays premiums plus interest during the early period and 100% thereafter; one source describes Golden Solution's return-of-premium as refunding 110% of premiums if death occurs in the first three years, or two years for those over 65 [13].

Coverage limits vary by source and tier. The Lighthouse Legacy agent guide states a $25,000 maximum for graded and return-of-premium plans, with immediate-benefit coverage capped at $50,000 for ages 50–75 and $25,000 for ages 76–85 [10]. Independent reviews describe final expense coverage ranging from $2,500 to $35,000 [15], and one directory lists up to $50,000 for ages 50–75 and up to $25,000 for ages 76–85 [17]. All of these ranges include the buyer's $15,000–$25,000 target.

What the AI Platforms Agreed About

Questions This Section Answers

  • What do AI platforms agree on about American Amicable for seniors with stable heart conditions?
  • Is American Amicable competitive for immediate day-one coverage after a cardiac event more than three years ago?

The platforms agreed on several points. First, American Amicable uses simplified-issue underwriting with no medical exam, blood test, or urine sample, relying instead on health questions, a possible telephone interview, and MIB and prescription-database checks [18]. Second, the product family offers three benefit tiers—immediate, graded, and return-of-premium—that create a possible path for applicants with older or less severe cardiac histories [18].

Third, multiple platforms reported that cardiac events occurring more than roughly three years in the past may qualify for immediate full coverage. One agent-oriented review states that most cardiac events after three years—heart attacks, strokes, stents—may qualify for immediate death benefit coverage [25]. The same source reports that blood thinners such as coumadin, warfarin, and clopidogrel are underwritten on a first-fill basis, meaning graded or immediate coverage may be available depending on how long ago the first prescription was filled [28]. Atrial fibrillation and arrhythmia are described as acceptable for immediate coverage [30].

Fourth, the platforms agreed that congestive heart failure is a major limitation. The Lighthouse Legacy underwriting guide lists medically diagnosed, treated, or hospitalized CHF as no coverage [31]. The Golden Solution agent guide places CHF and cardiomyopathy in the knockout questions that result in outright decline [32]. Independent reviews likewise describe CHF as an automatic decline for health-question plans [34].

Where the AI Platforms Disagreed or Were Uncertain

Questions This Section Answers

  • Which American Amicable final expense product names are actually verified, and which are uncertain?
  • How much does American Amicable cost per month for a $15,000 to $25,000 policy for a buyer with heart conditions?

The platforms disagreed or were uncertain on product naming, pricing, and the severity threshold for cardiac acceptance. On naming, the ranking stage supplied Eagle Premier Final Expense Whole Life, Lighthouse Legacy, Golden Solution, and Senior Choice. One platform identified Eagle Premier as an Americo product rather than an American Amicable product [36]. Another could not verify Eagle Premier, Lighthouse Legacy, or Golden Solution in official-source results and identified Senior Choice as the confirmed product [37]. A third verified Lighthouse Legacy directly through a company agent guide [38]. The supplied evidence does not resolve which names are current, which are discontinued, or which are competitor products.

On pricing, no platform produced a verified premium for the target buyer. The Lighthouse Legacy agent guide provides annual per-$1,000 rates, a $40 annual policy fee, and a published example of a 65-year-old non-tobacco male at $64.51 per month for $10,000 of immediate-benefit coverage including the policy fee and monthly EFT factor—explicitly not a quote for the target buyer [38]. One platform estimated level day-one coverage for stable cardiac histories at roughly $45–$65 per month per $10,000 at age 65, and modified coverage at $55–$80, but labeled these as industry tier benchmarks rather than American Amicable rates [39]. Another platform reported that exact premiums are not publicly listed and require an agent quote [40]. Pricing confidence was rated low by two platforms and moderate by two others.

On cardiac severity thresholds, the platforms were directionally consistent but not identical. One platform described a two-year lookback for graded coverage and a three-year lookback for immediate coverage [41]. Another described treatment, diagnosis, or hospitalization within two years mapping to return-of-premium and within three years mapping to graded, with immediate eligibility possible after the lookback period [42]. A third reported that applicants must answer "no" to heart disease on the simplified-issue application and that conditions diagnosed or treated within the past two to three years may face graded benefits or denial [43]. These are compatible but not identical descriptions, and the exact lookback for a specific diagnosis should be confirmed with the carrier.

Use-Case-Specific Features and Capabilities

Questions This Section Answers

  • What cardiac conditions does American Amicable's underwriting guide specifically address for final expense coverage?
  • Does American Amicable include terminal illness or nursing home benefits on its final expense policies?

American Amicable's underwriting material is unusually specific about cardiac histories. The Lighthouse Legacy medical impairment and prescription reference guide addresses angina, angioplasty, cardiomyopathy, catheterization, CHF, bypass surgery, defibrillator, heart attack, heart surgery, pacemaker, and related cardiac histories [45]. The guide generally maps treatment, diagnosis, or hospitalization within two years to the return-of-premium plan and within three years to the graded plan for several cardiac conditions, with immediate-benefit eligibility possible after the listed lookback period, subject to the full application and underwriting decision [45].

Included features vary by plan. The Lighthouse Legacy guide lists a terminal-illness accelerated-benefit rider as included where available on all plans, with a confined-care accelerated-benefit rider and nursing-home waiver listed for the immediate-benefit plan only [46]. Independent reviews describe a terminal illness rider included at no extra cost on most policies and a critical illness rider that pays a lump sum for covered conditions including heart attack or stroke [47]. One consumer brochure describes a nursing home benefit paying 5.0% of the face amount per month if confined at least 30 days after policy issue [49]. The Senior Choice brochure states terminal illness acceleration may pay up to 100% if life expectancy is 12 months or fewer, or 24 months in some states [50].

The application process is described as simplified issue with a possible point-of-sale decision. The Lighthouse Legacy guide states the mobile application decision engine can provide a point-of-sale underwriting outcome within seconds after application completion, though a telephone interview or further review may still be required [46]. Independent reviews describe approval typically within 24–48 hours, or within one to three business days [51].

Pricing, Fees, Contracts, and Ongoing Costs

Questions This Section Answers

  • What fees and policy charges apply to American Amicable final expense coverage for a buyer with heart conditions?
  • Are American Amicable final expense premiums guaranteed never to increase?

Exact pricing for the target buyer is not publicly available. The Lighthouse Legacy agent guide provides annual per-$1,000 rates for immediate and graded plans, separate tobacco and non-tobacco rates, and a $40 annual policy fee described as commissionable [53]. The published example—a 65-year-old non-tobacco male at $64.51 per month for $10,000 of immediate-benefit coverage including the policy fee and monthly EFT factor—is explicitly not a quote for the target buyer [53]. One platform reported a policy fee typically in the $30–$40 range [54]. Another reported no disclosed application or underwriting fees and no medical exam fees, with optional riders carrying additional cost [55].

Contract terms are more consistent across sources. Premiums are payable to age 100 for Lighthouse Legacy [53]. Independent reviews state that level premiums are guaranteed never to increase regardless of age or health changes and that the death benefit remains level [56]. Whole life policies build cash value that can be borrowed against [56]. The graded plan reduces the death benefit during the first two policy years, and the return-of-premium plan does not provide the full face amount during its stated early period [53]. One platform reported a standard 30-day free-look period [58]. The public agent guide does not provide a complete state-specific free-look, surrender, lapse, reinstatement, or cancellation summary, so buyers should verify the delivered policy and state forms [53].

Cost positioning is mixed. One platform reported that simplified-issue policies typically run higher premiums than fully underwritten coverage from larger competitors, and that graded and return-of-premium plans are significantly pricier than immediate plans [59]. The same platform reported that women typically pay 20–25% less than men and that male smokers pay significantly more than with some competitors [61]. Another platform described American Amicable as frequently cited for competitive day-one coverage on stable heart disease and often among the lowest rates in the simplified-issue market [63]. These positions are not fully reconciled in the supplied evidence.

Best Suited For

Questions This Section Answers

  • Who is American Amicable best suited for among seniors with heart conditions seeking final expense coverage?
  • Is American Amicable a good fit for a buyer on cardiac blood thinners like warfarin or clopidogrel?

American Amicable is best suited for applicants ages 50–85 seeking approximately $15,000–$25,000 of permanent coverage who have a past heart attack, heart surgery, bypass surgery, angioplasty, angina, pacemaker, or related condition where the relevant lookback period has elapsed [64]. It is also suited for applicants who may qualify for graded or return-of-premium benefits rather than immediate benefits, and for applicants on cardiac medications such as coumadin, warfarin, or clopidogrel where the first prescription fill was three or more years in the past [66]. Applicants with controlled atrial fibrillation or arrhythmia are described as acceptable for immediate coverage [68]. One platform also described the company as competitive for smokers and those with multiple health concerns [70].

Probably Not Best Suited For

Questions This Section Answers

  • Who should not choose American Amicable for Final Expense Insurance for People With Heart Conditions?
  • Does American Amicable offer guaranteed-issue final expense coverage with no health questions?

American Amicable is probably not best suited for applicants currently diagnosed with, treated for, or hospitalized for congestive heart failure, since CHF is listed as no coverage under the referenced Lighthouse Legacy criteria and appears in the Golden Solution knockout questions [71]. It is also not suited for applicants with very recent heart attack, heart surgery, bypass surgery, angioplasty, pacemaker insertion, or other recent cardiac treatment, who may only qualify for return-of-premium or graded benefits [71]. Applicants who require guaranteed-issue coverage without health questions or prescription and MIB review should look elsewhere, because American Amicable does not offer guaranteed-issue final expense policies [74]. Buyers who want online self-service quoting may also be frustrated, since exact pricing requires agent contact [76].

When Another Option May Be Better

Questions This Section Answers

  • When is a guaranteed-issue carrier a better choice than American Amicable for a senior with congestive heart failure?
  • When should a buyer with a recent heart attack choose a different carrier than American Amicable?

Another option may be better in several situations. If the applicant has current or severe congestive heart failure, a guaranteed-issue policy may be the only path, though with higher cost and a graded benefit period [77]. One platform specifically named Royal Neighbors as sometimes writing stable CHF at level when others decline [77]. If the buyer recently had a major cardiac event and needs full first-day coverage, one platform suggested Trinity Life as more forgiving with recent cardiac events and moderate heart conditions, and Aetna as known for flexible cardiac underwriting [79]. If the buyer needs coverage above $35,000, American Amicable's maximum may be insufficient, and larger carriers such as Mutual of Omaha, Aetna, or Transamerica were suggested [79]. If the buyer prefers online quoting and self-service application, digital-first competitors were suggested [79]. If the buyer is in perfect health and wants a lower premium per dollar of coverage, fully underwritten term or standard whole life policies may be cheaper [80].

Questions to Verify Before Buying

Questions This Section Answers

  • What should a buyer confirm with American Amicable before signing a final expense contract with a cardiac history?
  • Which issuing company in the American Amicable group will issue the policy in the buyer's state?

Before buying, verify which issuing company in the American Amicable group will issue the policy in the buyer's state [82]. Confirm, for the exact diagnosis, date of diagnosis, treatment dates, hospitalization dates, medications, and current status, whether the applicant is eligible for immediate, graded, return-of-premium, or no coverage [82]. Ask whether a history of CHF, reduced ejection fraction, cardiomyopathy, pacemaker or defibrillator, valve disease, bypass, angioplasty, or heart attack triggers a different result under the state-specific application [82]. Request the exact death benefit payable in each of the first three policy years [82]. Obtain the final monthly, quarterly, semiannual, and annual premium, including the $40 policy fee and any rider charges [82]. Confirm whether terminal-illness, confined-care, and nursing-home benefits are available in the buyer's state and how accelerated benefits reduce the death benefit [82]. Ask about cash-value, surrender, lapse, reinstatement, grace-period, and nonforfeiture provisions [82]. Confirm whether a telephone interview, MIB inquiry, prescription-data review, or additional records will be required [82]. Request the actual state-approved policy form and illustration before payment [82]. Note that in IA, MA, MI, NJ, RI, and VT, coverage is provided through sister company Occidental Life rather than under the American Amicable brand [85].

Final AI Consensus Verdict

American Amicable is a good, diagnosis-dependent fit for a senior with heart conditions seeking $15,000–$25,000 of permanent final expense coverage. Four of seven platforms named it during ranking discovery, and six of seven returned a usable fit assessment, with four rating it good and two rating it mixed. Its strongest asset for this use case is a simplified-issue whole life lineup—Senior Choice, Golden Solution, and Lighthouse Legacy—that offers immediate, graded, and return-of-premium benefit structures and underwriting guidance that specifically addresses several cardiac histories, including heart attack, bypass, angioplasty, pacemaker, and atrial fibrillation after the relevant lookback period. Its main limitation is that current or documented congestive heart failure is listed as no coverage, and recent major cardiac events may only qualify for graded or return-of-premium benefits rather than full first-day coverage. Product naming, exact pricing, and state-specific terms remain unresolved in the supplied evidence and should be confirmed directly with the carrier before applying.

How This Review Was Produced

This review was produced from platform-reported research responses collected for the topic "Best Final Expense Insurance for People With Heart Conditions" with a research date of 2026-09-22. Seven platforms were configured for the study. Four platforms named American Amicable during the ranking stage, and six returned a usable fit assessment. Each platform's response included its own citations, which are referenced in this article using the format (platform:citation_id). The supplied URLs were collected from platform responses and were not independently validated by the writer stage. Citations are platform-reported evidence, not independently verified facts. No-search model claims require explicit verification before being described as current facts. The consensus index for this topic is available at Final Expense Insurance for People With Heart Conditions, and the broader category directory is at life insurance.

Methodology Limitations

Several limitations apply. Six of seven included platforms returned a usable fit assessment, so the fit findings should not be described as unanimous. Platform-reported research dates differ from the authoritative run date of 2026-09-22; platform dates are provenance metadata and do not independently prove freshness. The supplied URLs were collected from platform responses and were not independently validated by the writer stage. Conflicting product names, pricing, and capabilities were not resolved by guessing; the conflicts are described and buyers are directed to verify. The deterministic identity audit contains qualification notes that are disclosed where relevant. No independent source was located that independently verifies American Amicable's cardiac acceptance outcomes or typical approval rates. The agent guide states that products, riders, application questions, and availability can vary by state, and the underwriting guide states its medical impairment guide is not all-inclusive and reserves the final decision to underwriting. Exact public pricing for the target buyer is unavailable without personal underwriting variables.

Explore more life insurance guidance in the category directory.

Sources

Company-Owned Sources

  • Lighthouse Legacy Whole Life Insurance Agent Guide: https://www.americanamicable.com/internet/webforms/common/3140.pdf
  • Normalization audit context supplied by deterministic ranking stage: https://www.americanamicable.com/v4/index.php
  • Additional AI research evidence85 records
    1. AI research evidence record openai:c1
    2. AI research evidence record anthropic:8-4
    3. AI research evidence record google:2.4.8
    4. AI research evidence record anthropic:26-3
    5. AI research evidence record perplexity:c1
    6. AI research evidence record perplexity:c1
    7. AI research evidence record anthropic:26-3
    8. AI research evidence record google:2.4.1
    9. AI research evidence record anthropic:22-1
    10. AI research evidence record openai:c1
    11. AI research evidence record anthropic:8-13
    12. AI research evidence record google:1.2.4
    13. AI research evidence record anthropic:20-1
    14. AI research evidence record google:2.2.9
    15. AI research evidence record anthropic:12-1
    16. AI research evidence record anthropic:17-16
    17. AI research evidence record anthropic:29-4
    18. AI research evidence record openai:c1
    19. AI research evidence record anthropic:17-2
    20. AI research evidence record google:2.3.7
    21. AI research evidence record grok:1
    22. AI research evidence record anthropic:8-4
    23. AI research evidence record google:2.4.8
    24. AI research evidence record perplexity:c1
    25. AI research evidence record anthropic:31-7
    26. AI research evidence record anthropic:14-10
    27. AI research evidence record grok:0
    28. AI research evidence record anthropic:31-8
    29. AI research evidence record anthropic:5-4
    30. AI research evidence record anthropic:31-5
    31. AI research evidence record openai:c2
    32. AI research evidence record google:3.2.1
    33. AI research evidence record google:3.2.4
    34. AI research evidence record anthropic:4-6
    35. AI research evidence record kimi:burial-chf-2026
    36. AI research evidence record anthropic:26-3
    37. AI research evidence record perplexity:c1
    38. AI research evidence record openai:c1
    39. AI research evidence record kimi:asurgo-heart-2026
    40. AI research evidence record anthropic:37-10
    41. AI research evidence record grok:0
    42. AI research evidence record openai:c2
    43. AI research evidence record anthropic:3-1
    44. AI research evidence record anthropic:32-2
    45. AI research evidence record openai:c2
    46. AI research evidence record openai:c1
    47. AI research evidence record anthropic:6-8
    48. AI research evidence record anthropic:6-10
    49. AI research evidence record anthropic:25-2
    50. AI research evidence record perplexity:c1
    51. AI research evidence record anthropic:17-3
    52. AI research evidence record anthropic:33-5
    53. AI research evidence record openai:c1
    54. AI research evidence record grok:0
    55. AI research evidence record anthropic:6-8
    56. AI research evidence record anthropic:15-5
    57. AI research evidence record openai:c3
    58. AI research evidence record google:2.4.8
    59. AI research evidence record anthropic:30-5
    60. AI research evidence record anthropic:35-2
    61. AI research evidence record anthropic:10-2
    62. AI research evidence record anthropic:37-8
    63. AI research evidence record kimi:burial-insurance-2026
    64. AI research evidence record openai:c2
    65. AI research evidence record anthropic:31-7
    66. AI research evidence record anthropic:31-8
    67. AI research evidence record anthropic:5-5
    68. AI research evidence record anthropic:31-5
    69. AI research evidence record grok:0
    70. AI research evidence record anthropic:20-4
    71. AI research evidence record openai:c2
    72. AI research evidence record google:3.2.1
    73. AI research evidence record anthropic:3-1
    74. AI research evidence record anthropic:35-4
    75. AI research evidence record kimi:aflac-comparison-2026
    76. AI research evidence record anthropic:37-10
    77. AI research evidence record kimi:burial-chf-2026
    78. AI research evidence record kimi:moneygeek-chf-2026
    79. AI research evidence record anthropic:3-5
    80. AI research evidence record google:3.2.4
    81. AI research evidence record anthropic:30-5
    82. AI research evidence record openai:c1
    83. AI research evidence record perplexity:c1
    84. AI research evidence record anthropic:3-2
    85. AI research evidence record anthropic:29-16

Independent Sources

Other Sources

  • Top 22 Final Expense Insurance Companies For Agents: https://davidduford.com/best-final-expense-carriers/
  • American-Amicable Burial Insurance Review (2026): Senior Choice: https://theburialinsurance.com/american-amicable-burial-insurance-review/
  • Additional AI research evidence85 records
    1. AI research evidence record openai:c1
    2. AI research evidence record anthropic:8-4
    3. AI research evidence record google:2.4.8
    4. AI research evidence record anthropic:26-3
    5. AI research evidence record perplexity:c1
    6. AI research evidence record perplexity:c1
    7. AI research evidence record anthropic:26-3
    8. AI research evidence record google:2.4.1
    9. AI research evidence record anthropic:22-1
    10. AI research evidence record openai:c1
    11. AI research evidence record anthropic:8-13
    12. AI research evidence record google:1.2.4
    13. AI research evidence record anthropic:20-1
    14. AI research evidence record google:2.2.9
    15. AI research evidence record anthropic:12-1
    16. AI research evidence record anthropic:17-16
    17. AI research evidence record anthropic:29-4
    18. AI research evidence record openai:c1
    19. AI research evidence record anthropic:17-2
    20. AI research evidence record google:2.3.7
    21. AI research evidence record grok:1
    22. AI research evidence record anthropic:8-4
    23. AI research evidence record google:2.4.8
    24. AI research evidence record perplexity:c1
    25. AI research evidence record anthropic:31-7
    26. AI research evidence record anthropic:14-10
    27. AI research evidence record grok:0
    28. AI research evidence record anthropic:31-8
    29. AI research evidence record anthropic:5-4
    30. AI research evidence record anthropic:31-5
    31. AI research evidence record openai:c2
    32. AI research evidence record google:3.2.1
    33. AI research evidence record google:3.2.4
    34. AI research evidence record anthropic:4-6
    35. AI research evidence record kimi:burial-chf-2026
    36. AI research evidence record anthropic:26-3
    37. AI research evidence record perplexity:c1
    38. AI research evidence record openai:c1
    39. AI research evidence record kimi:asurgo-heart-2026
    40. AI research evidence record anthropic:37-10
    41. AI research evidence record grok:0
    42. AI research evidence record openai:c2
    43. AI research evidence record anthropic:3-1
    44. AI research evidence record anthropic:32-2
    45. AI research evidence record openai:c2
    46. AI research evidence record openai:c1
    47. AI research evidence record anthropic:6-8
    48. AI research evidence record anthropic:6-10
    49. AI research evidence record anthropic:25-2
    50. AI research evidence record perplexity:c1
    51. AI research evidence record anthropic:17-3
    52. AI research evidence record anthropic:33-5
    53. AI research evidence record openai:c1
    54. AI research evidence record grok:0
    55. AI research evidence record anthropic:6-8
    56. AI research evidence record anthropic:15-5
    57. AI research evidence record openai:c3
    58. AI research evidence record google:2.4.8
    59. AI research evidence record anthropic:30-5
    60. AI research evidence record anthropic:35-2
    61. AI research evidence record anthropic:10-2
    62. AI research evidence record anthropic:37-8
    63. AI research evidence record kimi:burial-insurance-2026
    64. AI research evidence record openai:c2
    65. AI research evidence record anthropic:31-7
    66. AI research evidence record anthropic:31-8
    67. AI research evidence record anthropic:5-5
    68. AI research evidence record anthropic:31-5
    69. AI research evidence record grok:0
    70. AI research evidence record anthropic:20-4
    71. AI research evidence record openai:c2
    72. AI research evidence record google:3.2.1
    73. AI research evidence record anthropic:3-1
    74. AI research evidence record anthropic:35-4
    75. AI research evidence record kimi:aflac-comparison-2026
    76. AI research evidence record anthropic:37-10
    77. AI research evidence record kimi:burial-chf-2026
    78. AI research evidence record kimi:moneygeek-chf-2026
    79. AI research evidence record anthropic:3-5
    80. AI research evidence record google:3.2.4
    81. AI research evidence record anthropic:30-5
    82. AI research evidence record openai:c1
    83. AI research evidence record perplexity:c1
    84. AI research evidence record anthropic:3-2
    85. AI research evidence record anthropic:29-16

Verify this research

Check when the research was run, which platforms were included, and what supports the findings.

Study date
September 22, 2026
Platforms analyzed
7
Source records
41
Ranking mentions
4 of 7
Platform share
57%
Final consensus rank
#5

Behind the findings

Platforms in this study

  • ChatGPT
  • Claude
  • DeepSeek
  • Grok
  • Perplexity
  • Kimi
  • Gemini

Source records

32 independent · 5 company-owned · 4 unclear

Evidence support

11 direct · 10 partial

Keep in mind

Use the run research_date as the study date. Platform-reported dates are provenance metadata and do not independently prove freshness.

Technical verification details

Use this SHA-256 fingerprint to identify the source snapshot associated with this study.

d535304fe6eb1cf0b9c9312fefe5e255590b117871839318c4288932c039f17e